Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris

Cardiovascular disease is a significant health concern. Risk factors include hypertension, obesity, dyslipidemia and smoking. Women who are postmenopausal are at an increased risk of heart disease. Here is the latest research for risk factors of cardiovascular disease.

Clinical efficacy of verapamil alone and combined with propranolol in treating patients with chronic stable angina pectoris

Abstract

References

Experimental studies on the pathogenesis of asystole after verapamil in the dog

Double-blind comparison of verapamil and practolol in the treatment of angina pectoris

Effects of intravenous verapamil on cardiac arrhythmias and on the electrocardiogram.

Some fundamental actions of antiarrhythmic drugs on the excitability and the contractility of singel myocardial fibers

Double-blind evaluation of verapamil, propranolol, and isosorbide dinitrate against a placebo in the treatment of angina pectoris

Effects of agents which inhibit the slow channel on sinus node automaticity and atrioventricular conduction in the dog

Effect of verapamil on the noraml action potential and on a calcium-dependent slow response of canine cardiac Purkinje fibers

Clinical evaluation of verapamil in angina pectoris

Importance of the design of an exercise protocol in the evaluation of patients with angina pectoris

Clinical and circulatory effects of isosorbide dinitrate. Comparison with nitroglycerin

New selective inhibitors of the transmembrane Ca conductivity in mammalian myocardial fibres. Studies with the voltage clamp technique

Selective suppression of some components of spontaneous activity in various types of smooth muscle by iproveratril (Verapamil)

Hemodynamic changes after beta adrenergic blockade

Citations

Pharmacology of acute effort angina

Comparison of the cardiovascular effects of nifedipine and nicardipine in the presence of atenolol.

Comparison of the antianginal efficacy of four calcium antagonists and propranolol in stable angina pectoris

Intrinsic and reflex actions of verapamil and nifedipine: assessment in normal subjects by noninvasive techniques and autonomic blockade

Comparison of the efficacy of atenolol and its combination with slow-release nifedipine in chronic stable angina

Calcium channel antagonists. Part II: Use and comparative properties of the three prototypical calcium antagonists in ischemic heart disease, including recommendations based on an analysis of 41 trials

Calcium antagonists: a new class of drugs

Response of angina and ischemia to long-term treatment in patients with chronic stable angina: a double-blind randomized individualized dosing trial of nifedipine, propranolol and their combination

Calcium channel antagonists in the management of anginal syndromes: changing concepts in relation to the role of coronary vasospasm

Clinical value of calcium antagonists in treatment of cardiovascular disorders

Randomized, double-blind comparison of propranolol alone and a propranolol-verapamil combination in patients with severe angina of effort

A dose-ranging, placebo-controlled, double-blind trial of nisoldipine in effort angina: duration and extent of antianginal effects

Evaluation of potential pharmacodynamic and pharmacokinetic interactions between verapamil and propranolol in normal subjects

Additive antianginal effect of verapamil in patients receiving propranolol

Additive antianginal effect of verapamil in patients receiving propranolol

Acute and chronic haemodynamic and electrophysiological effects of nifedipine in patients receiving atenolol

Treatment of angina pectoris with nifedipine and atenolol: efficacy and effect on cardiac function

A double blind placebo controlled comparison of verapamil, atenolol, and their combination in patients with chronic stable angina pectoris

Impaired blood pressure response to exercise in patients with coronary artery disease: possible contribution of attenuated reflex vasoconstriction in non-exercising muscles

Probable adverse interaction between oral metoprolol and verapamil

Tolerability of combined treatment with verapamil and beta-blockers in angina resistant to monotherapy

Combination of metoprolol with molsidomine in the treatment of angina pectoris

Role of calcium channel blockers in clinical medicine

Selection of optimal drug therapy for the patient with angina pectoris

Stable angina pectoris: 3. Medical treatment

Stable angina pectoris: the medical management of symptomatic myocardial ischemia

Effect of calcium entry and beta blockade during infrarenal aortic clamping

Clinical and hemodynamic evaluation of propranolol in combination with verapamil, nifedipine and diltiazem in exertional angina pectoris: a placebo-controlled, double-blind, randomized, crossover study

Diltiazem and propranolol in combination: hemodynamic effects following acute intravenous administration

Improved exercise tolerance after propranolol, diltiazem or nifedipine in angina pectoris: comparison at 1, 3 and 8 hours and correlation with plasma drug concentration

Hemodynamic effects of nifedipine given alone and in combination with atenolol in patients with impaired left ventricular function

Propranolol-verapamil versus propranolol-nifedipine in severe angina pectoris of effort: a randomized, double-blind, crossover study

Acute hemodynamic effects of intravenous nicardipine in patients treated chronically with propranolol for coronary artery disease

Combination propranolol and bepridil therapy in stable angina pectoris

Comparative effects of calcium-channel blocking agents on left ventricular function during acute ischemia in dogs with and without congestive heart failure

Dynamic coronary obstruction as a cause of angina pectoris: implications regarding therapy

Calcium-entry blocking agents in the treatment of systemic hypertension

Coronary spasm, steal, and stenosis: implications for management of ischemic heart disease

Rational approach to the medical therapy of angina pectoris: the role of calcium antagonists

Randomized, placebo-controlled study of the effect of verapamil on exercise hemodynamics in coronary artery disease

Combined verapamil and propranolol for supraventricular tachycardia

Calcium antagonists for chronic stable angina pectoris.

Calcium entry blocking drugs: mechanisms of action, experimental studies and clinical uses

Is exertional hypotension a useful indicator of high risk coronary artery disease?

Calcium channel blocking drugs for chronic, stable angina

Calcium-channel blockers and beta blockers: advantages and disadvantages of combination therapy in chronic stable angina pectoris

Efficacy of drug therapy in the secondary prevention of cardiovascular disease and stroke

Diltiazem and propranolol combination for the treatment of chronic stable angina pectoris

Comparison of nifedipine alone with propranolol alone for stable angina pectoris including hemodynamics at rest and during exercise

Hemodynamic and electrophysiologic effects of verapamil and nifedipine in patients on propranolol

Related Concepts

Related Feeds

Cardiovascular Diseases: Risk Factors

Related Papers

Combined therapy with verapamil and propranolol in chronic stable angina

Verapamil versus placebo in relieving stable angina pectoris

A double-blind randomized trial of propranolol and verapamil in the treatment of effort angina

Hemodynamic consequences of combined beta-adrenergic and slow calcium channel blockade in man

Objective assessment of antianginal treatment: a double-blind comparison of propranolol, nifedipine, and their combination